Every 10-Q that Reed's, Inc. (REED) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow REED and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full REED filings page.
Reed’s, Inc. reported sharply lower sales and continued losses for the quarter and six months ended June 30, 2026, while showing some improvement in quarterly margins. Net sales were $7.5 million for the quarter and $14.6 million year‑to‑date, down 21% and 25% from 2025, driven by volume declines with recurring national customers and selective product liquidation.
Quarterly gross margin improved to 24% of net sales from 8% a year earlier, helped by lower inventory write‑offs and reduced delivery costs per case, though year‑to‑date gross margin slipped to 17% from 22%. Reed’s still posted a quarterly net loss of $4.3 million and a six‑month net loss of $10.7 million, with EBITDA remaining negative.
Liquidity is strained: as of June 30, 2026 cash was $2.4 million against a $9.25 million Senior Secured Loan maturing September 30, 2026, no remaining loan availability, and a stockholders’ deficit of $1.5 million. Management disclosed that these factors raise substantial doubt about the company’s ability to continue as a going concern and also highlighted the NYSE American notice that Reed’s is below certain stockholders’ equity listing standards.
Reed’s, Inc. reported a much weaker first quarter of 2026. Net sales fell to $7,142 thousand from $10,029 thousand a year earlier, a 29% decline driven by lower volumes and heavier promotional discounts. Gross margin shrank to 10% of net sales from 34%, hurt by $738 thousand of inventory write-offs tied to product portfolio changes and higher cost per case.
Operating expenses rose to $6,912 thousand, up 34%, with general and administrative costs more than doubling to support an Asia-Pacific growth initiative. The company’s net loss widened to $6,464 thousand, or $0.55 per share, versus a loss of $2,031 thousand, or $0.27 per share. EBITDA was a loss of $6,218 thousand.
Cash decreased to $4,580 thousand as of March 31, 2026, from $10,424 thousand at year-end 2025, mainly due to operating losses and working capital needs. Reed’s has a fully drawn senior secured loan of $9,250 thousand and no remaining availability, but management believes existing cash, operations, and committed financing can fund the approved operating plan for at least twelve months.
Reed’s, Inc. reported third-quarter results and updated its capital structure. Q3 net sales were $7.033 million, up 4% year over year, with gross margin at 17%. Operating loss was $4.103 million and net loss was $3.982 million (loss per share $0.48).
For the nine months ended September 30, 2025, net sales were $26.585 million (down 6%), cost of goods sold rose 7%, and gross margin was 20%. Net loss was $12.061 million and cash used in operations totaled $13.230 million, driven in part by $1.775 million of inventory write‑offs tied to product portfolio changes.
Liquidity actions included two private placements—$3.0 million in June (537,632 shares) and $5.0 million in September (833,330 shares). Cash was $4.136 million at September 30, 2025. The Senior Secured Loan was amended: the revolving commitment was reduced to $9.250 million, interest is now paid monthly, and maturity was extended to September 30, 2026; outstanding principal was $9.250 million with $0 remaining availability. On October 31, 2025, the company effected a 1‑for‑6 reverse stock split, and had 8,945,454 common shares outstanding as of October 31, 2025.